Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Allison Makovec, John T. Phoenix, Hannah E. Bergom, Ella Boytim, Ava P. Gustafson, Aiden Deacon, Sydney Tape, Atef Ali, Megan Ludwig, Samuel P. Pitzen, David Moline, Camden Richter, Hudson Longie, Mei-Chi Su, Sampreeti Jena, Pornlada Likasitwatanakul, Justin M. Drake, R. Stephanie Huang, William C. Hahn, Jonathan P. Rennhack, Scott M. Dehm, Steven Kregel, Emmanuel S. Antonarakis, Justin Hwang
Published Mar 30, 2026 · Vol. 17, No. 1 · pp. 59-73
Waseem Al-Jameel, Xiaojun Gou, Shiva S. Forootan, Majed Saad Al Fayi, Philip S. Rudland, Farzad S. Forootan, Jiacheng Zhang, Philip A. Cornford, Syed A. Hussain, Youqiang Ke
Published Jul 21, 2020 · Vol. 11, No. 31 · pp. 3025-3025
Souhila Abdelfettah, Gaylor Boulay, Marion Dubuissez, Nathalie Spruyt, Sara P. Garcia, Shruthi Rengarajan, Ingrid Loison, Xavier Leroy, Miguel N. Rivera, Dominique Leprince
Published Mar 24, 2020 · Vol. 11, No. 12 · pp. 1051-1074
Keywords: hPCL3S, PHF19, PRC2, β-catenin, prostate cancer
Sarah Bonk, Martina Kluth, Claudia Hube-Magg, Adam Polonski, Greta Soekeland, Georgia Makropidi-Fraune, Christina Möller-Koop, Melanie Witt, Andreas M. Luebke, Andrea Hinsch, Eike Burandt, Stefan Steurer, Till S. Clauditz, Thorsten Schlomm, Daniel Perez, Markus Graefen, Hans Heinzer, Hartwig Huland, Jakob R. Izbicki, Waldemar Wilczak, Sarah Minner, Guido Sauter, Ronald Simon
Published Sep 10, 2019 · Vol. 10, No. 52 · pp. 5439-5453
Keywords: prostate specific antigen, specificity, immunohistochemistry, prognosis marker, tissue microarray